AVB Biotechnology is a privately held joint-stock company established with the mission of transforming a universal law into technology in the field of bioelectrical medicine. This structure enables us to implement a long-term strategy based on scientific depth, independent of short-term market expectations.

Board of Directors

Our Board of Directors, which is our strategic decision-making body, is structured with a predominantly academic composition. Our members consist of leading experts in their respective fields. This structure ensures that scientific vision and corporate governance meet at the same table, and that every strategic decision is made on an evidence-based foundation.

Scientific Board

Our Scientific Board is the highest scientific advisory body that conducts the independent audit of our validation architecture, directs our clinical data generation processes, and guides the expansion of our technology to new indications.

Quality and Regulatory Compliance

The entire life cycle of the Biomimetic Bioelectrical Modulation System—from its design to production, and from clinical validation to post-market surveillance—is conducted within the framework of international standards and regulations, primarily ISO 13485, ISO 14971, MDR (EU) 2017/745, FDA guidelines, and MEDDEV/MDCG guidelines. For detailed information, please visit our Quality System page.

Global Vision

We act with the vision of delivering the clinical and commercial counterpart of a scientifically validated biological law to the entire world. This vision progresses on two parallel axes:

• Scientific Axis: To build the scientific authority of biomimetic modulation on a global scale through international congresses, peer-reviewed publications, and multi-center clinical trials.
• Commercial Axis: To deliver our technology to every geography where unmet medical needs exist, through regional licensing strategies, distribution partnerships, and local clinical validation studies.